Search

1 to 2 of 2
Sort by

Library Entry
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes

Genome editing offers unique perspectives for optimizing the functional properties of T cells for adoptive cell transfer purposes. So far, PDCD1 editing has been successfully tested mainly in chimeric antigen receptor T (CAR-T) cells and human primary T cells. Nonetheless, for patients with...


Library Entry
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors

Immune checkpoint inhibitor (ICI)-associated early cardiac adverse events (CAEs), mostly acute and fulminant myocarditis, have been well characterized and mainly occur during the first 90 days after ICI therapy initiation. ICI-associated late CAEs (occurring after the first 90 days of treatment)...